Document text
Principal Investigator: Andrea Goldstein-Piekarski
Organization: STANFORD UNIVERSITY
Fiscal Year: 2024
Award: $98,828
Funding agency: National Institute of Mental Health
PROJECT SUMMARY/ABSTRACT
BACKGROUND: Several independent lines of evidence suggest that sleep disturbance may directly contribute
to the generation and maintenance of neuropsychiatric symptoms (NPS) including anxiety, depression, agitation,
irritability, and apathy through fronto-limbic brain networks that regulate emotion, particularly in regions of the
prefrontal cortex (PFC) and limbic areas (amygdala). However, the model of sleep disturbance contributing to
increased NPS through impairments in fronto-limbic function has not yet been tested in a sample of participants
with or at high-risk for developing Alzheimer’s Disease (AD). OBJECTIVE: We aim to test this model in patients
with mild cognitive impairment (MCI) and mild AD by characterizing associations between sleep disruption,
fronto-limbic function while regulating emotion, and NPS at baseline and by experimentally manipulating sleep to
determine whether changes in sleep cause downstream alterations in fronto-limbic functioning and NPS.
DESIGN/METHODS: Our hypotheses will be tested in a 2-arm randomized controlled mechanistic trial with 150
patients with MCI and mild AD experiencing sleep disturbances who are also experiencing emotional distress
and other behavioral symptoms. Participants will be randomized in a 1:1 ratio to receive a sleep manipulation
(Cognitive Behavioral Therapy for Insomnia; CBT-I) or to the credible control treatment for insomnia group.
Both interventions will be administered in six sessions delivered over eight weeks. CBT-I is an efficacious
behavioral intervention specifically targeted at improving sleep patterns through a combination of sleep
restriction, stimulus control, cognitive therapy targeting dysfunctional beliefs about sleep, and sleep hygiene
education. At baseline, and post-sleep manipulation we will assay each participant’s fronto-limbic functioning
while regulating emotions (amygdala reactivity and PFC-amygdala connectivity), NPS using the Neuropsychiatric
Inventory (NPI), and sleep efficiency using high-density EEG collected overnight during sleep. SPECIFIC AIMS
are to 1) characterize baseline associations among sleep disturbances, emotion regulation brain function, and
NPS prior to a sleep manipulation, 2) test that sleep-induced fronto-limbic brain function improvement mediates
the association between sleep improvement and NPS reductions, and 3) determine baseline predictors of the
NPS improvement. NOVELTY & IMPACT: Using a multi-methodological approach within a mechanistic trial
framework by causally manipulating sleep, we will uncover potential NPS mechanisms across multiple units of
analysis (brain circuit, physiological, behavioral, and self-report). Our results will advance a mechanistic
understanding of how sleep disturbances and fronto-limbic brain function while regulating emotions may
underlie the emotionally distressing and economically relevant problem of NPS in early AD patients. These
results would be a necessary first step in the development of sleep based, mechanism-focused preventative
strategies and treatments that are more personalized for the individual.
Terms: <AD dementia><Agitation><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's disease patient><Alzheimer's patient><Alzheimers Dementia><Amygdala><Amygdaloid Body><Amygdaloid Nucleus><Amygdaloid structure><Anxiety><Area><Assay><Behavior Conditioning Therapy><Behavior Modification><Behavior Therapy><Behavior Treatment><Behavioral><Behavioral Conditioning Therapy><Behavioral Modification><Behavioral Symptoms><Behavioral Therapy><Behavioral Treatment><Belief><Bioassay><Biological Assay><Brain><Brain Nervous System><Clinical><Cognition Therapy><Cognitive Psychotherapy><Cognitive Therapy><Cognitive treatment><Conditioning Therapy><Development><Distress><EEG><Education><Educational aspects><Electroencephalogram><Electroencephalography><Emotions><Encephalon><Equipment and supply inventories><Foundations><Generations><Impairment><Individual><Insomnia><Insomnia Disorder><Intervention><Intervention Strategies><Inventory><Maintenance><Mediating><Mental Depression><Methodology><Methods><Modeling><Participant><Patient Self-Report><Patients><Physiologic><Physiological><Prefrontal Cortex><Preventative strategy><Preventative treatment><Prevention strategy><Preventive strategy><Preventive treatment><Primary Senile Degenerative Dementia><Psychomotor Agitation><Psychomotor Excitement><Psychomotor Hyperactivity><Psychomotor Restlessness><Randomized><Restlessness><Sampling><Self-Report><Sleep><Sleep disturbances><Sleeplessness><Stimulus><Testing><aberrant sleep><abnormal brain function><alleviate symptom><ameliorating symptom><amygdaloid nuclear complex><arm><behavior intervention><behavioral intervention><brain dysfunction><brain impairment><cognitive behavior intervention><cognitive behavior modification><cognitive behavior therapy><cognitive behavioral intervention><cognitive behavioral modification><cognitive behavioral therapy><cognitive behavioral treatment><decrease symptom><density><depression><developmental><disrupted sleep><disturbed sleep><dysfunctional brain><emotion regulation><emotional distress><emotional experience><emotional regulation><experience><feeling distress><feeling upset><fewer symptoms><high risk><impaired sleep><improve symptom><improved><improvement on sleep><innovate><innovation><innovative><interventional strategy><irregular sleep><mild cognitive disorder><mild cognitive impairment><multi-modal neuro-imaging><multi-modal neuroimaging><multimodal neuro-imaging><multimodal neuroimaging><neuropsychiatric><neuropsychiatric symptom><neuropsychiatry><patient living with Alzheimer's disease><patient suffering from Alzheimer's disease><patient with Alzheimer's><patient with Alzheimer's disease><primary degenerative dementia><randomisation><randomization><randomly assigned><reduce symptoms><relieves symptoms><senile dementia of the Alzheimer type><sleep disruption><sleep dysregulation><sleep health><sleep hygiene><sleep improvement><sleep pattern><symptom alleviation><symptom improvement><symptom reduction><symptom relief><symptomatic improvement><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment>